STEPHANIE BRENNEMAN: Open Payments
NPI 1932520426 · ELKHART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 21 payments from 10 companies in 2025. Trend: 2023 $466 · 2024 $102 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 6 | $180 |
| Ardelyx, Inc. | 2 | $140 |
| Exeltis, USA Inc. | 3 | $64 |
| PFIZER INC. | 3 | $55 |
| Ethicon US, LLC | 1 | $46 |
| Biogen, Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $29 |
| Organon LLC | 1 | $26 |
| Octapharma USA, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
Products named: IBSRELA, ANNOVERA, SLYND, ABRYSVO, VISTASEAL, ZURZUVAE, Veozah, NEXPLANON.
Industry payments across IN — which companies pay providers there.
